Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ACTRN12626001170314) titled 'Implementation of CYP2C19 testing to guide antiplatelet therapy' on Sept. 21.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Non-randomised trial
Masking: Open (masking not used)
Primary Sponsor: University of Sydney
Condition:
Acute Coronary Syndrome
Recurrent Ischaemic Events
Coronary Artery Disease
Acute Coronary Syndrome
Recurrent Ischaemic Events
Coronary Artery Disease
Cardiovascular - Coronary heart disease
Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system
Intervention:
This is a hybrid type 3 implementation trial evaluating a...